Ultra Seal Corporation recalls Ephedrine Plus (Ephedrine HCl 25mg, Guaifenesin 200mg) tablets, 24-count bottles, Marketed by: DMD Pharmaceuticals A Div
Recalled February 9, 2022 · FDA recall D-0473-2022 · Ultra Seal
Hazard
cGMP deviations · FDA Class II
Units
301,842 bottles
Sold at
Nationwide within the United States
Description
cGMP deviations
Product
Ephedrine Plus (Ephedrine HCl 25mg, Guaifenesin 200mg) tablets, 24-count bottles, Marketed by: DMD Pharmaceuticals A Division of Dickery Consumer Products, Inc. Noblesville, IN 46060, NDC 65193-320-24
Manufacturer(s)
Ultra Seal Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →